About the Company
We do not have any company description for COGNITION THERAPEUTICS INC at the moment.
Exchange
Nasdaq
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest News on COGNITION THERAPEUTICS INC
Cognition Therapeutics Shares Surge After FDA Confirms Phase 3 Trial Design
Cognition Therapeutics Inc (NASDAQ:CGTX) saw its stock jump 27% following FDA confirmation that the company’s proposed Phase ...
Cognition Therapeutics Reports Q2 2025 Financial Results
Cognition Therapeutics, Inc. ( ($CGTX) ) has released its Q2 earnings. Here is a breakdown of the information Cognition Therapeutics, Inc.
Cognition Therapeutics, Inc.
Cognition Therapeutics, Inc. is a clinical stage neuroscience company which engages in developing drugs that help restore normal cellular damage responses in neurodegenerative and neuro-ophthalmic ...
Cognition Therapeutics, Inc. Reports Promising Results for Zervimesine ...
Cognition Therapeutics, Inc. Reports Promising Results for Zervimesine in Phase 2 Alzheimer’s and Dementia with Lewy Bodies Studies July 16, 2025 — 07:42 am EDT ...
CGTX - Cognition Therapeutics Inc News | Morningstar
Cognition Therapeutics to Report Biomarker Results from Phase 2 SHINE Study in Mild-to-Moderate Alzheimer’s Disease in Podium Presentation at AD/PD 2025 GlobeNewswire Mar 25, 2025, 4:30:57 AM ...
Cognition Therapeutics, Inc. (CGTX) Q4 2023 Earnings Call Transcript
Cognition Therapeutics, Inc. (CGTX) Q4 2023 Earnings Call Transcript Mar. 26, 2024 12:02 PM ET Cognition Therapeutics, Inc. (CGTX) Stock CGTX SA Transcripts 153.14K Follower s ...
Cognition Therapeutics, Inc.: Cognition Therapeutics Reports Financial ...
Aktien»Nachrichten»COGNITION THERAPEUTICS AKTIE» COGNITION THERAPEUTICS INC WKN: A3C46P|ISIN: US19243B1026|Ticker-Symbol: NASDAQ 23.07.25 | 21:59 0,807US-Dollar 0,00 % 0,000 Branche Biotechnologie ...
Cognition Therapeutics, Inc.: Cognition Therapeutics Completes End-of ...
Cognition Therapeutics, Inc., is a clinical-stage biopharmaceutical company discovering and developing innovative, small molecule therapeutics targeting age-related degenerative disorders of the ...
Cognition Therapeutics, Inc. CEO Lisa Ricciardi to Present at Life ...
Cognition Therapeutics, Inc. announced that its President and CEO, Lisa Ricciardi, will present at the Life Sciences Virtual Investor Conference on March 13, 2025, at 9:30 a.m. ET.
Cognition Therapeutics Inc. | BioWorld
Cognition Therapeutics Inc. said it is moving to the next stage of clinical testing with oral, small-molecule candidate CT-1812, despite phase II efficacy results falling short of statistical ...
Cognition Therapeutics, Inc. (CGTX) Q4 2022 Earnings Call Transcript
Cognition Therapeutics, Inc. (NASDAQ:CGTX) Q4 2022 Earnings Conference Call March 23, 2023 8:00 AM ETCompany ParticipantsDaniel Kontoh-Boateng - Investor ...
CGTX - Cognition Therapeutics Inc Chart | Morningstar
Cognition Therapeutics Inc CGTX Stock XNAS Rating as of Jun 13, 2025 Download PDF Summary Chart News Price vs Fair Value Sustainability Trailing Returns Key Metrics Financials Valuation Dividends ...
Similar Companies
Loading the latest forecasts...